TranspariMED clinical trial transparency

10 Jan 2020

The Director General of the Italian Medicines Agency AIFA, Dr. Luca Li Bassi, outlines his agency's plan to improve clinical trial reporting and enhance the transparency of markets for drugs, vaccines and health technologies in this guest blog.

"The availability and full access to transparent information on clinical trials contributes to the protection of public health as w...

Please reload

Subscribe
Recent Posts
Please reload

This site was designed with the
.com
website builder. Create your website today.
Start Now